X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19) 19
radioimmunotherapy (19) 19
animals (18) 18
mice (16) 16
humans (14) 14
female (13) 13
radioimmunotherapy - methods (13) 13
hematology (10) 10
article (9) 9
oncology (9) 9
xenograft model antitumor assays (9) 9
abridged index medicus (7) 7
leukocyte common antigens - immunology (7) 7
cell line, tumor (6) 6
lymphoma (6) 6
radioisotopes (6) 6
therapy (6) 6
total-body irradiation (6) 6
transplantation (6) 6
cd45 (5) 5
follicular lymphoma (5) 5
leukemia (5) 5
mice, nude (5) 5
neoplasms (5) 5
pretargeted radioimmunotherapy (5) 5
radiologi och bildbehandling (5) 5
radiology, nuclear medicine and medical imaging (5) 5
tissue distribution (5) 5
toxicity (5) 5
antibodies, monoclonal - immunology (4) 4
antibodies, monoclonal - therapeutic use (4) 4
biotin - analogs & derivatives (4) 4
cancer (4) 4
cyclophosphamide (4) 4
disease models, animal (4) 4
immunology (4) 4
irradiation (4) 4
leukocyte common antigens - antagonists & inhibitors (4) 4
lymphoid neoplasia (4) 4
lymphoma, b-cell - radiotherapy (4) 4
lymphomas (4) 4
mice, inbred balb c (4) 4
monoclonal antibodies (4) 4
monoclonal-antibodies (4) 4
non-hodgkin-lymphoma (4) 4
non-hodgkins-lymphoma (4) 4
radiology and nuclear medicine (4) 4
streptavidin fusion protein (4) 4
60 applied life sciences (3) 3
acute myeloid leukemia (3) 3
alpha imaging (3) 3
alpha particles (3) 3
antigens, cd20 - immunology (3) 3
astatine (3) 3
b-cell lymphomas (3) 3
biotin - pharmacology (3) 3
bismuth 213 (3) 3
cd20 (3) 3
cells, cultured (3) 3
dogs (3) 3
dosimetry (3) 3
hemic and lymphatic diseases (3) 3
i-131 tositumomab (3) 3
immune system diseases (3) 3
immunotherapy (3) 3
leukemia - therapy (3) 3
lymphoma, b-cell - pathology (3) 3
lymphoma, non-hodgkin - immunology (3) 3
lymphoma, non-hodgkin - radiotherapy (3) 3
male (3) 3
myeloid leukemia (3) 3
organometallic compounds - pharmacology (3) 3
patients (3) 3
phase-i (3) 3
pretargeting (3) 3
proteins (3) 3
radiation therapy (3) 3
radiations (3) 3
radioactivity (3) 3
radionuclide imaging (3) 3
streptavidin - pharmacology (3) 3
targets (3) 3
treatment outcome (3) 3
acute myeloid-leukemia (2) 2
acute-leukemia (2) 2
adp-ribosyl cyclase 1 - immunology (2) 2
antibodies, monoclonal - pharmacology (2) 2
antigens (2) 2
astatine - pharmacokinetics (2) 2
astatine - therapeutic use (2) 2
astatine 211 (2) 2
astatine-211 (2) 2
autoradiography (2) 2
basic biological sciences (2) 2
biology and life sciences (2) 2
biotin - pharmacokinetics (2) 2
bismuth - pharmacokinetics (2) 2
bismuth - pharmacology (2) 2
blood (2) 2
bone marrow (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
PLoS ONE, ISSN 1932-6203, 10/2018, Volume 13, Issue 10, p. e0205135
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 14, pp. 3885 - 3893
Journal Article
Blood, ISSN 0006-4971, 08/2019, Volume 134, Issue 15, pp. 1247 - 1256
Minimal residual disease (MRD) has become an increasingly prevalent and important entity in multiple myeloma (MM). Despite deepening responses to frontline... 
Journal Article
PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 12, pp. e113601 - e113601
Journal Article
Blood, ISSN 0006-4971, 2009, Volume 114, Issue 6, pp. 1226 - 1335
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1941 - 1941
Abstract Introduction Multiple myeloma (MM) is considered incurable but patients achieving minimal-residual disease (MRD) negative status following treatment... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 467 - 467
Abstract Introduction: An estimated 19,970 Americans died of non-Hodgkin lymphoma (NHL) in 2015, with diffuse large B-cell lymphoma (DLBCL) accounting for... 
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 2908 - 2908
Abstract Introduction Acute Myeloid Leukemia (AML) relapse rates remain high despite treatment with combination chemotherapy and hematopoietic cell... 
Journal Article
Infection and Immunity, ISSN 0019-9567, 12/2006, Volume 74, Issue 12, pp. 6847 - 6854
The human {beta}-defensin 3 (hBD-3) is an inducible epithelial peptide antibiotic that has potent antistaphylococcal activity. Infection of skin epithelial... 
Journal Article
Journal of Immunotherapy, ISSN 1524-9557, 2018, Volume 41, Issue 1, pp. 19 - 31
Journal Article
Blood, ISSN 0006-4971, 05/2013, Volume 121, Issue 18, pp. 3759 - 3767
Despite aggressive chemotherapy combined with hematopoietic stem cell transplantation (HSCT), many patients with acute myeloid leukemia (AML) relapse.... 
TOTAL-BODY IRRADIATION | LONG-TERM | PRETARGETED RADIOIMMUNOTHERAPY | CYCLOPHOSPHAMIDE | ALPHA-PARTICLE THERAPY | CELL TRANSPLANTATION | ACUTE MYELOID-LEUKEMIA | MONOCLONAL-ANTIBODIES | HEMATOLOGY | PHASE-I | MYELODYSPLASTIC SYNDROME
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 11/2015, Volume 56, Issue 11, p. 1766
  α-radioimmunotherapy targeting CD45 may substitute for total-body irradiation in hematopoietic cell transplantation (HCT) preparative regimens for lymphoma.... 
Flow cytometry | Nuclear medicine | Toxicity | Immunotherapy | Dogs | Monoclonal antibodies
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 11/2015, Volume 56, Issue 11, pp. 1766 - 1766
-radioimmunotherapy targeting CD45 may substitute for total-body irradiation in hematopoietic cell transplantation (HCT) preparative regimens for lymphoma. Our... 
Journal Article